Related Experiment Video
Updated: Mar 15, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Personalized medicine in psychiatry
Ida Kim Wium-Andersen1, Maj Vinberg2, Lars Vedel Kessing2
1a Psychiatric Center Ballerup , Ballerup , Denmark.
Personalized medicine uses individual patient data for tailored treatments. In psychiatry, overcoming broad diagnostic categories is key to advancing personalized approaches and bridging research with clinical practice.
Area of Science:
- Medical Science
- Genomics
- Psychiatry
Background:
- Personalized medicine tailors treatment and prevention strategies based on a patient's unique clinical, genetic, and environmental profile.
- This approach represents a shift from one-size-fits-all medical practices.
Purpose of the Study:
- To review current tools and biomarkers for personalized medicine.
- To explore applications in diagnostics, treatment selection, and risk assessment.
- To identify challenges and solutions for implementing personalized medicine in psychiatry.
Main Methods:
- Literature review of existing research on personalized medicine tools and biomarkers.
- Analysis of phenomenological features, clinical risk factors, and biomarkers.
- Examination of applications in diagnostics, treatment, and prevention.
Main Results:
- Identified key tools, features, risk factors, and biomarkers for personalized medicine.
- Detailed applications in diagnostics, treatment selection, side-effect risk assessment, and prevention.
- Highlighted the gap between research and clinical practice in psychiatry due to diagnostic limitations.
Conclusions:
- Current psychiatric diagnostic categories are too broad for effective biological research and personalized medicine.
- Significant heterogeneity within diagnostic groups hinders the development of targeted therapies.
- Solutions are proposed to bridge the gap between research and clinical practice, advancing personalized psychiatry.
More Related Videos
05:19Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
Drug Therapy
Antianxiety Medications
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenomics: Identification of New Drug Targets
Dosage Regimen: Individualization